10-Year Outcomes of Deferred or Conventional Stent Implantation in Patients With STEMI (DANAMI-3-DEFER)
Authors:
- Jasmine Melissa MarquardJMJasmine Melissa Marquard
- Thomas EngstrømTEThomas Engstrøm
- Henning KelbækHKHenning Kelbæk
- Rasmus Paulin BeskeRBRasmus Paulin Beske
- Utsho IslamUIUtsho Islam
- Dan Eik HøfstenDHDan Eik Høfsten
- Lene HolmvangLHLene Holmvang
- Frants PedersenFPFrants Pedersen
- Christian Juhl TerkelsenCTChristian Juhl Terkelsen
- Evald Høj ChristiansenECEvald Høj Christiansen
- Hans-Henrik TilstedHTHans-Henrik Tilsted
- Charlotte GlingeCGCharlotte Glinge
Open Access
- 1 June 2025
- journal article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (6) , e015369
Abstract
BACKGROUND: Primary percutaneous coronary intervention (PCI) with stenting is recommended in ST-segment–elevation myocardial infarction. Immediate stenting may cause distal embolization, microvascular damage, and flow disturbances, leading to adverse outcomes. We report the 10-year clinical outcomes of deferred stenting versus conventional PCI in patients with ST-segment–elevation myocardial infarction. METHODS: We conducted a 10-year follow-up study of the open-label, randomized DANAMI-3-DEFER trial (Third Danish Study of Optimal Acute Treatment of Patients With STEMI – Deferred Stent Implantation Versus Conventional Treatment), conducted in 4 PCI centers in Denmark. Patients with ST-segment–elevation myocardial infarction and acute chest pain 24 hours after the index procedure or conventional PCI with immediate stenting. In the deferred group, immediate stable Thrombolysis in Myocardial Infarction flow II to III was established, and intravenous administration of either a glycoprotein IIb/IIIa antagonist or bivalirudin for >4 hours after the index procedure was recommended. The primary outcome was a composite of hospitalization for heart failure or all-cause mortality. Key secondary outcomes included individual components of the primary outcome and target vessel revascularization. RESULTS: Of 1215 patients, 603 were randomized to deferred stenting and 612 to conventional PCI. After 10 years, deferred stenting did not significantly reduce the primary composite outcome (hazard ratio, 0.82 [95% CI, 0.67–1.02]; P =0.08). In the deferred group, 124 (24%) died versus 150 (25%) in the conventional PCI group (hazard ratio, 0.95 [95% CI, 0.75–1.19]). Hospitalization for heart failure was lower in patients treated with deferred stenting compared with conventional PCI (odds ratio, 0.58 [95% CI, 0.39–0.88]). Target vessel revascularization was similar in both groups (odds ratio, 1.20 [95% CI, 0.81–1.79]). CONCLUSIONS: Deferred stenting did not reduce all-cause mortality or the composite primary outcome after 10 years but reduced hospitalization for heart failure compared with conventional PCI. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01435408.Keywords
This publication has 26 references indexed in Scilit:
- Prehospital Pulse-Dose Glucocorticoid in ST-Segment Elevation Myocardial InfarctionJAMA Cardiology, 2024
- Restenosis, Stent Thrombosis, and Bleeding ComplicationsJACC, 2018
- Myocardial Damage in Patients With Deferred Stenting After STEMIJACC, 2017
- Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial InfarctionJAMA Cardiology, 2017
- Management of No-Reflow Phenomenon in the Catheterization LaboratoryJACC: Cardiovascular Interventions, 2017
- Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trialThe Lancet, 2016
- Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trialThe Lancet, 2015
- The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion onlyAmerican Heart Journal, 2015
- A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI)JACC, 2014
- Randomized Comparison of Distal Protection Versus Conventional Treatment in Primary Percutaneous Coronary InterventionJACC, 2008